Trials / Completed
CompletedNCT03561519
FMT in the Treatment of IBS
FECAL MICROBIOTA TRANSPLANTATION IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Joint Authority for Päijät-Häme Social and Health Care · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
52 adult IBS patients were recruited. 50% were given a fecal microbiota transplantation in colonoscopy and 50% were given an FMT made of their own feces as placebo. follow up time was 1 year after FMT.
Detailed description
52 adult IBS patients of any subgroup(IBS-D, IBS-C or IBS-M), were recruited and given an FMT in colonoscopy. Neither the patient nor the care taking personnel did know in which group the patients belonged to. The patients were screened with fecal samples for 16RNA sequencing and they were repeatedly done IBS-SSS questionnaire and questionnaires for quality of life and psychical condition. Follow up time was 1 year after the colonoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fecal Microbiota Transplantation (FMT) | Fecal suspension administered in colonoscopy into the cecum of the patient. |
| OTHER | Placebo | As a placebo a fecal suspension made of patients own feces is administered into the cecum of the patient in colonoscopy. |
Timeline
- Start date
- 2015-08-27
- Primary completion
- 2018-07-01
- Completion
- 2018-07-01
- First posted
- 2018-06-19
- Last updated
- 2018-08-15
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT03561519. Inclusion in this directory is not an endorsement.